{"id":29763,"date":"2023-03-13T11:03:27","date_gmt":"2023-03-13T11:03:27","guid":{"rendered":"http:\/\/myanmarnewswire.com\/?guid=a6ec8e1eebe151542f2148498513f897"},"modified":"2023-03-13T11:03:27","modified_gmt":"2023-03-13T11:03:27","slug":"resmeds-annual-global-sleep-survey-finds-8-in-10-adults-experience-signs-of-disruption-related-to-their-quality-of-sleep","status":"publish","type":"post","link":"https:\/\/myanmarnewswire.com\/resmeds-annual-global-sleep-survey-finds-8-in-10-adults-experience-signs-of-disruption-related-to-their-quality-of-sleep\/","title":{"rendered":"ResMed\u2019s Annual Global Sleep Survey Finds 8 in 10 Adults\u00a0Experience Signs of Disruption Related to Their Quality of Sleep"},"content":{"rendered":"
SAN DIEGO, March 13, 2023 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) announced today the results from its 2023 Global Sleep Survey in conjunction with National Sleep Awareness Week (March 12-18) and World Sleep Day (March 17) to raise awareness for the importance of sleep as a key component of physical and mental health.<\/p>\n
The survey found that despite 64% of respondents saying they are satisfied with the quantity of their sleep, more than 80% report experiencing symptoms of disruption related to their sleep quality, with consumers most commonly reporting mood changes, such as depression or irritability (33%), waking up with a dry mouth or sore throat (30%), difficulty concentrating during the day (30%), and excessive daytime sleepiness (29%).<\/p>\n
The 2023 Global Sleep Survey asked more than 20,000 respondents from 12 countries during January 2023 about the quantity and quality of their sleep, bedtime routines, and sleep habits and found differences in respondents\u2019 quantity and quality of sleep based on location, gender, and age:<\/p>\n
Despite a majority of survey respondents reporting they wake up with symptoms of poor sleep quality \u2013 one-third (33%) of respondents have not been tested for sleep apnea or sought medical help for other sleep conditions because they do not believe they have sleep-related medical conditions. Additionally, 49% of respondents said their doctor has never asked them proactively about their sleep quality.<\/p>\n
\u201cPrioritizing sleep is one of the most effective ways to improve your health, and poor sleep can increase the risk of diabetes, obesity, heart disease, and depression,\u201d said Carlos M. Nunez, M.D., chief medical officer for ResMed. \u201cIt\u2019s critical to have an honest discussion with your healthcare provider about your sleep habits and seek help if you\u2019re experiencing patterns or symptoms of poor sleep as it could point to a more concerning health issue or sleep disorder such as sleep apnea.\u201d<\/p>\n
What\u2019s Keeping People Up at Night and Tools They\u2019re Using to Improve Their Sleep <\/strong> To learn more about ResMed\u2019s 2023 Global Sleep Survey or to take a quick self-assessment for your risk of sleep apnea, visit SleepForBetterTomorrow.com<\/a>. Plus, learn about the digital health technologies that are transforming how we sleep, breathe, live, and care for patients on ResMed\u2019s new podcast series, Awaken Your Best<\/a>, hosted by Dr. Nunez and available anywhere you stream your favorite podcasts including on Spotify and Apple Podcasts. The first episode premiers today \u2013 Monday, March 13 \u2013 featuring a conversation on the latest digital health trends with Gary Shapiro, acclaimed author and president and CEO of the Consumer Technology Association.<\/p>\n Survey Methodology<\/strong> For generational comparisons, the survey defines Gen Z as ages 18-26, Millennials ages 27-42, Gen X ages 43-58, Baby Boomers ages 59-77, and the Silent Generation ages 78-95.<\/p>\n About ResMed<\/strong>
\nAdditional findings of ResMed\u2019s 2023 Global Sleep Survey address what\u2019s keeping people up at night and how people use technology to improve sleep. Findings include:<\/p>\n\n
\nResMed 2023 Global Sleep Survey included 20,069 total participants across the United States, the United Kingdom, Germany, France, South Korea, Mexico, Japan, Singapore, Australia, Brazil, China, and India, conducted in January 2023.<\/p>\n
\nAt ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies\u201d and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.\u00a0To learn more, visit ResMed.com<\/a> and follow @ResMed.<\/p>\n